About Indivior PLC (LON:INDV)
Indivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia. Its products are Suboxone Film (buprenorphine and naloxone), Suboxone Tablet (buprenorphine and naloxone), and Subutex Tablet (buprenorphine). Its other products include RBP-6000 in ATRIGEL, RBP-7000 risperidone monthly depot, Arbaclofen placarbil for alcohol use disorder (AUD), Intranasal naloxone for treatment of opioid overdose and RBP-8000 cocaine esterase for cocaine intoxication. Its RBP-6000 buprenorphine monthly depot is developed for the treatment of opioid use disorder. Its RBP-7000 risperidone monthly depot is developed for treatment of schizophrenia.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Specialty & Advanced Pharmaceuticals
- Sub-Industry: N/A
- Symbol: LON:INDV
- CUSIP: N/A
- Web: indivior.com/
Capitalization:- Market Cap: £2.36 billion
- Outstanding Shares: 720,988,000
Average Prices:- 50 Day Moving Avg: GBX 325.90
- 200 Day Moving Avg: GBX 336.25
- 52 Week Range: GBX 246.50 - GBX 421.50
P/E:- Trailing P/E Ratio: 30.23
- P/E Growth: -0.43
Sales & Book Value:- Annual Revenue: £1.08 billion
- Price / Sales: 2.19
- Book Value: GBX (0.18) per share
- Price / Book: -18.21
Profitability:- EBITDA: £228 million
- Net Margins: 25.35%
- Return on Assets: 22.93%
Misc:- Average Volume: 2.77 million shs.
Frequently Asked Questions for Indivior PLC (LON:INDV)
What is Indivior PLC's stock symbol?
Indivior PLC trades on the London Stock Exchange (LON) under the ticker symbol "INDV."
Where is Indivior PLC's stock going? Where will Indivior PLC's stock price be in 2017?
6 analysts have issued 1 year price targets for Indivior PLC's stock. Their forecasts range from GBX 280 to GBX 500. On average, they expect Indivior PLC's share price to reach GBX 400.50 in the next year. View Analyst Ratings for Indivior PLC.
Who are some of Indivior PLC's key competitors?
Some companies that are related to Indivior PLC include ConvaTec Group PLC (CTEC), Mallinckrodt PLC (MNK), Advanced Accelerator Applications S.A. (AAAP), Supernus Pharmaceuticals (SUPN), Aimmune Therapeutics (AIMT), Repligen Corporation (RGEN), TherapeuticsMD (TXMD), TherapeuticsMD (TXMD), Eagle Pharmaceuticals (EGRX), Assembly Biosciences (ASMB), Rockwell Medical (RMTI), NOVAN INC (NOVN), CorMedix (CRMD), Check-Cap (CHEK), DARA Biosciences (DARA), Macrocure Ltd (MCUR) and Salix Pharmaceuticals (SLXP).
Who are Indivior PLC's key executives?
Indivior PLC's management team includes the folowing people:
- Howard Pien, Executive Chairman of the Board
- Shaun Thaxter, Chief Executive Officer, Executive Director
- Mark Crossley, Chief Financial Officer, Executive Director
- Jon Fogle, Chief Human Resource Officer
- Ingo Elfering, Chief Information Officer
- Christian Heidbreder, Chief Scientific Officer
- Kathryn Hudson, Company Secretary
- Tatjana May, Non-Executive Director
- A. Thomas McLellan Ph.D., Non-Executive Director
- Daniel Tasse, Senior Independent Director
How do I buy Indivior PLC stock?
Shares of Indivior PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Indivior PLC's stock price today?
One share of Indivior PLC stock can currently be purchased for approximately GBX 327.80.
MarketBeat Community Rating for Indivior PLC (LON INDV)MarketBeat's community ratings are surveys of what our community members think about Indivior PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Indivior PLC (LON:INDV) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating, 5 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.83) |
| Consensus Price Target: | GBX 400.50 |
Consensus Price Target History for Indivior PLC (LON:INDV)
Analysts' Ratings History for Indivior PLC (LON:INDV)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 10/20/2017 | Numis Securities Ltd | Reiterated Rating | Buy | GBX 500 |  |
| 9/15/2017 | Stifel Nicolaus | Reiterated Rating | Buy | GBX 400 | |
| 9/8/2017 | Jefferies Group LLC | Lower Price Target | Buy | GBX 540 -> GBX 358 | |
| 9/5/2017 | Citigroup Inc. | Reiterated Rating | Neutral | GBX 280 | |
| 8/3/2017 | Royal Bank Of Canada | Reiterated Rating | Outperform | GBX 470 | |
| 2/23/2017 | Deutsche Bank AG | Reiterated Rating | Buy | GBX 395 | |
| 8/1/2016 | Morgan Stanley | Boost Price Target | Overweight | GBX 280 -> GBX 330 | |
(Data available from 10/20/2015 forward)
Earnings History for Indivior PLC (LON:INDV)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Indivior PLC (LON:INDV)Current Year EPS Consensus Estimate: $0.38 EPS
Dividend History for Indivior PLC (LON:INDV)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Indivior PLC (LON:INDV)Insider Trades by Quarter for Indivior PLC (LON:INDV)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 2/24/2017 | Lorna Parker | Insider | Buy | 1,231 | GBX 342 | £4,210.02 | |
| 5/12/2016 | Tassé,Daniel | Insider | Buy | 3,903 | GBX 161 | £6,283.83 | |
| 5/13/2015 | Daniel Tassé | Insider | Buy | 6,209 | GBX 229.28 | £14,236 | |
| 3/27/2015 | Shaun Thaxter | Insider | Buy | 20,000 | GBX 196 | £39,200 | |
| 3/26/2015 | Shaun Thaxter | Insider | Buy | 10,000 | GBX 197.17 | £19,717 | |
| 2/16/2015 | Shaun Thaxter | Insider | Buy | 35,000 | GBX 161.59 | £56,556.50 | |
| 2/13/2015 | Cary Claiborne | Insider | Buy | 62,000 | GBX 166.24 | £103,068.80 | |
| 2/12/2015 | Cary Claiborne | Insider | Buy | 23,780 | GBX 170 | £40,426 | |
| 2/11/2015 | Shaun Thaxter | Insider | Buy | 10,000 | GBX 163.36 | £16,336 | |
(Data available from 1/1/2013 forward)
Headline Trends for Indivior PLC (LON:INDV)
Latest Headlines for Indivior PLC (LON:INDV)
| Source: |
|
Indivior PLC (INDV) Chart for Friday, October, 20, 2017
